X. Long Zheng/LinkedIn
Nov 17, 2026, 01:27
X. Long Zheng: Optimizing Treatment in Immune TTP
X. Long Zheng, Professor and Chair of Pathology and Laboratory Medicine at The University of Kansas, shared a post on LinkedIn about a recent article he and his colleague co-authored, published in Expert Review of Hematology, adding:
“Our new invited article on guided precision management of immune thrombotic thrombocytopenic purpura (iTTP) is now published in the Expert Review of Hematology.
This review summarizes current and potentially future therapeutics for iTTP.”
Title: Guided precision management of iTTP: optimizing treatment, monitoring, and relapse prevention
Authors: Huan Donga, X. Long Zheng

Other posts featuring X. Long Zheng on Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments